Competition, and what each rival's incentives predict

Every large firm has deployed an internal AI assistant to its consultants — McKinsey's Lilli, Bain's Sage, and equivalents across the Big Four — on essentially the same 2023-2024 timeline.

The rule governing their behavior is that their revenue is a function of hours billed and their margin is a function of hours delivered per dollar of salary. An AI tool that cuts the hours needed to produce an analysis improves the second and destroys the first, so they will deploy it internally to raise margin and will not sell it as a product that replaces the engagement. That is exactly what the observed behavior shows.

What this predicts: they do not become software competitors. They become faster and cheaper providers of the same engagement, which compresses the price umbrella Innovera is currently selling under.

The same rule read the other way is the strongest thing that can be said for Innovera's position. A firm with no billable hours to protect loses nothing by automating the work, so the cannibalization that stops a consulting firm productizing its internal tools does not apply here. That asymmetry, rather than any claim about the technology, is why the analysis step is attackable at all by a company this size.

The competitive comparison in the deck shows Innovera at $50,000 against $200-500K for mid-tier and $800K-1.5M for tier one. That gap is the thing that closes.

Outcome-based pricing is the second signal: McKinsey is reported to take a growing share of fees on outcome terms. A firm willing to price on outcomes is a firm preparing to defend on value rather than hours.

Searching for a venture-backed company doing AI-generated market-entry business cases for enterprises returned no direct match, across three searches by the option-generation agent and a further search in this analysis. That is a weak negative and should be read as "not found in four searches" rather than "does not exist" — companies at this size are largely invisible to general search, and absence of a competitor in search results is not evidence of an empty market.

The honest position is that the direct competitive set is unknown. Establishing it is cheap and should be done before the next investor conversation, because "who else does this" is a question that will be asked and "nobody" is an answer that invites a counterexample.

Gartner published its inaugural Magic Quadrant for Decision Intelligence Platforms in 2026, naming FICO, Aera Technology, SAS, IBM, ACTICO and Quantexa as Leaders. These platforms model decisions explicitly, orchestrate them at scale, and monitor decision quality continuously.

The rule governing them is that they monetize decision volume: their economics work where a decision repeats thousands of times, which is why the category has settled on credit, supply chain and pricing. A one-off market-entry commitment has no volume to amortize a platform against, so the category has no incentive to move toward it and is unlikely to.

Two consequences. Innovera is not competing with these vendors for the same work, and should not be positioned as though it were. But a buyer who has seen this category has already been sold the language of continuously governed, auditable decisions, which is the language Innovera uses, and will ask how the two differ. Having an answer is cheap; being surprised by the question is not.

The rule here is build-versus-buy applied to a capability close to what the organization believes it competes on. Corporate strategy groups are small, a few dozen people at most, even at the largest companies, and they are the client's own judgment function. They will buy tools that make them faster and resist tools that appear to replace their judgment, because the judgment is what justifies the function's existence.

This predicts that the sale lands better as augmentation of a strategy team than as a substitute for one, and that a pitch built on "the wisdom of a seasoned executive, for every team" reads to the buyer as a threat rather than a benefit. Positioning matters more than price in this group.

The material does not address this group, and it is the one whose incentives point most directly at Innovera's position. Innovera's product is structured reasoning over a client's documents plus retrieved external evidence, delivered through an agent architecture. That is a description of the reference workload the labs are building agent products around.

The rule governing lab behavior is that they compete on capability demonstrations in high-value knowledge work and monetize breadth rather than depth. This predicts they will continue to make the general capability cheaper and better without building the enterprise- specific pieces, the gated engagement, the accountable human sign-off, the client's data governance, the institutional relationships. It also predicts that anything Innovera's product does that is only a wrapper on general reasoning gets absorbed.

What survives contact with that is the part that is not reasoning: the claims graph as a durable record, the four-phase method with accountability at each gate, the expert network, and the accumulated comparative data. What does not survive is any defensibility claim resting on prompt structure or framework encoding.

A new entrant carrying none of the incumbent's assets applies the same rule and reaches a different answer: a firm starting today would build exactly what Innovera has built, and would take about as long, which is the real measure of the head start.

Separating the claims that survive the analysis above from those that do not:

The honest summary is that the defensibility is operational rather than technological: a method that works, a record nobody else keeps, and relationships that open doors. That is a real position and it is worth stating plainly, because a defensibility claim resting on prompt structure or framework encoding will not survive a technical diligence conversation.

Which route to market follows from this rather than from preference. Building direct enterprise distribution is the expensive path and the one the plan assumes. Partnering — supplying the innovation-management and portfolio incumbents, or white-labeling to mid-tier consultancies — uses somebody else's distribution against Innovera's strongest asset, and costs a share of the revenue rather than the cost of a sales organization. The material does not evaluate the second, and at current cash it is the cheaper experiment.